1. Home
  2. WULF vs MIRM Comparison

WULF vs MIRM Comparison

Compare WULF & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WULF
  • MIRM
  • Stock Information
  • Founded
  • WULF 1952
  • MIRM 2018
  • Country
  • WULF United States
  • MIRM United States
  • Employees
  • WULF N/A
  • MIRM N/A
  • Industry
  • WULF EDP Services
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • WULF Technology
  • MIRM Health Care
  • Exchange
  • WULF Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • WULF 4.5B
  • MIRM 3.7B
  • IPO Year
  • WULF 1995
  • MIRM 2019
  • Fundamental
  • Price
  • WULF $14.83
  • MIRM $73.48
  • Analyst Decision
  • WULF Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • WULF 12
  • MIRM 11
  • Target Price
  • WULF $16.71
  • MIRM $82.82
  • AVG Volume (30 Days)
  • WULF 48.9M
  • MIRM 614.2K
  • Earning Date
  • WULF 11-10-2025
  • MIRM 11-04-2025
  • Dividend Yield
  • WULF N/A
  • MIRM N/A
  • EPS Growth
  • WULF N/A
  • MIRM N/A
  • EPS
  • WULF N/A
  • MIRM N/A
  • Revenue
  • WULF $167,604,000.00
  • MIRM $471,794,000.00
  • Revenue This Year
  • WULF $41.01
  • MIRM $53.14
  • Revenue Next Year
  • WULF $118.36
  • MIRM $19.83
  • P/E Ratio
  • WULF N/A
  • MIRM N/A
  • Revenue Growth
  • WULF 30.58
  • MIRM 53.66
  • 52 Week Low
  • WULF $2.06
  • MIRM $36.88
  • 52 Week High
  • WULF $17.05
  • MIRM $78.55
  • Technical
  • Relative Strength Index (RSI)
  • WULF 59.75
  • MIRM 56.60
  • Support Level
  • WULF $10.47
  • MIRM $68.96
  • Resistance Level
  • WULF $14.75
  • MIRM $73.96
  • Average True Range (ATR)
  • WULF 1.46
  • MIRM 2.85
  • MACD
  • WULF 0.11
  • MIRM 0.30
  • Stochastic Oscillator
  • WULF 92.49
  • MIRM 84.56

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: